Empowering chimeric antigen receptor T-cell therapy with CRISPR

Bibliographic Details
Published in:	BioTechniques
Main Author:	Xuanzhu Zhou
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2020-04-01
Subjects:	CAR-T cell therapy CRISPR CRISPR HDR template
Online Access:	https://www.future-science.com/doi/10.2144/btn-2019-0107

Similar Items

Increasing Gene Editing Efficiency via CRISPR/Cas9- or Cas12a-Mediated Knock-In in Primary Human T Cells
by: Natalia Kruglova, et al.
Published: (2024-01-01)

Chimeric antigen receptor T cells applied to solid tumors
by: Zhongguo Zhou, et al.
Published: (2022-10-01)

Optimizing the DNA Donor Template for Homology-Directed Repair of Double-Strand Breaks
by: Fei Song, et al.
Published: (2017-06-01)

Non-viral chimeric antigen receptor (CAR) T cells going viral
by: H. Balke-Want, et al.
Published: (2023-06-01)

Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
by: Jiangtao Ren, et al.
Published: (2017-04-01)

Genome editing approaches for universal chimeric antigen receptor T cells
by: Avijeet Kumar Mishra, et al.
Published: (2024-06-01)

CRISPR-Cas and CRISPR-based screening system for precise gene editing and targeted cancer therapy
by: Mingming Qin, et al.
Published: (2024-05-01)

CRISPR-mediated genome editing in poplar issued by efficient transformation
by: Ali Movahedi, et al.
Published: (2023-04-01)

Progress in CRISPR/Cas9 for CAR-T cell therapy of tumors
by: WU Qi, WANG Shaobo
Published: (2023-08-01)

Efficient In Vivo Introduction of Point Mutations Using ssODN and a Co-CRISPR Approach
by: Tgst Levi, et al.
Published: (2020-07-01)

CRISPR–Cas9 applications in T cells and adoptive T cell therapies
by: Xiaoying Chen, et al.
Published: (2024-04-01)

The role of amylase in bioethanol production: advances in amylase-producing strains using CRISPR/Cas9 Technology
by: Eshet Lakew Tesfaye, et al.
Published: (2025-06-01)

Optimizing CRISPR/Cas9 Editing of Repetitive Single Nucleotide Variants
by: Inga Usher, et al.
Published: (2022-07-01)

Impact of Formulation Conditions on Lipid Nanoparticle Characteristics and Functional Delivery of CRISPR RNP for Gene Knock-Out and Correction
by: Johanna Walther, et al.
Published: (2022-01-01)

CRISPR-mediated generation of a tumor-associated antigen-deficient Raji platform to investigate antigen loss in CAR-T cell therapy
by: Aditya Ramdas Iyer, et al.
Published: (2025-09-01)

Methodologies for Improving HDR Efficiency
by: Mingjie Liu, et al.
Published: (2019-01-01)

Successful CRISPR/Cas9-mediated HDR at individual DNA breakpoints using TFO-based targeted template design
by: Zahra Ebrahimi, et al.
Published: (2024-03-01)

CRISPR/Cas-based CAR-T cells: production and application
by: Ping Song, et al.
Published: (2024-05-01)

Erratic journey of CRISPR/Cas9 in oncology from bench-work to successful-clinical therapy
by: Esha Sarkar, et al.
Published: (2021-01-01)

Single-stranded DNA (ssDNA) donor repair templates and CRISPR/Cas9 enable a high-frequency of targeted insertions in potato
by: Matías N. González, et al.
Published: (2025-09-01)

CRISPR in Targeted Therapy and Adoptive T Cell Immunotherapy for Hepatocellular Carcinoma
by: Palaz F, et al.
Published: (2024-05-01)

A review on genome editing by CRISPR-Cas9 technique for cancer treatment
by: M. Niuz Morshed Khan, et al.
Published: (2020-03-01)

Characterization of the aryl hydrocarbon receptor as a potential candidate to improve cancer T cell therapies
by: Valentine De Castro, et al.
Published: (2025-05-01)

Homology-Directed-Repair-Based Genome Editing in HSPCs for the Treatment of Inborn Errors of Immunity and Blood Disorders
by: Daniel Allen, et al.
Published: (2023-04-01)

Guidelines for Fluorescent Guided Biallelic HDR Targeting Selection With PiggyBac System Removal for Gene Editing
by: Javier Jarazo, et al.
Published: (2019-03-01)

Application of HDR-CRISPR/Cas9 and Erythrocyte Binding for Rapid Generation of Recombinant Turkey Herpesvirus-Vectored Avian Influenza Virus Vaccines
by: Pengxiang Chang, et al.
Published: (2019-11-01)

Editorial: CRISPR and beyond: Cutting-edge technologies for gene correction in therapeutic applications
by: Ayal Hendel, et al.
Published: (2023-04-01)

Boosting CAR-T cell therapy with CRISPR technology
by: Liyanran Yan, et al.
Published: (2024-08-01)

Scalable intracellular delivery via microfluidic vortex shedding enhances the function of chimeric antigen receptor T-cells
by: Brandon J. Sytsma, et al.
Published: (2025-02-01)

Improving the Efficiency of CRISPR Ribonucleoprotein-Mediated Precise Gene Editing by Small Molecules in Porcine Fibroblasts
by: Yunjing Zhao, et al.
Published: (2024-02-01)

Present Status and Advances in Chimeric Antigen Receptor T Cell Therapy for Glioblastoma
by: Shuchang Zhou, et al.
Published: (2023-09-01)

Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
by: Haiqiong Zheng, et al.
Published: (2024-11-01)

CRISPR-Based Editing Techniques for Genetic Manipulation of Primary T Cells
by: Mateusz Kotowski, et al.
Published: (2020-11-01)

Research Trends and Challenges of Using CRISPR/Cas9 for Improving Rice Productivity
by: Van Trang Le, et al.
Published: (2022-01-01)

CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future
by: Fathema Uddin, et al.
Published: (2020-08-01)

CRISPR-Cas9-mediated homology-directed repair for precise gene editing
by: Hongyu Liao, et al.
Published: (2024-12-01)

HLA-A2 CAR/IL-2-CISC engineered Treg display robust in vitro and in vivo antigen-specific regulatory function
by: Subhash K. Tripathi, et al.
Published: (2025-09-01)

Optimizing cancer treatment: the synergistic potential of CAR-T cell therapy and CRISPR/Cas9
by: Maryam Amiri, et al.
Published: (2024-11-01)

CRISPR-screen informed engineered T cell therapies
by: Karrie Wong, et al.
Published: (2026-05-01)

Engineering T cell receptor fusion proteins using nonviral CRISPR/Cas9 genome editing for cancer immunotherapy
by: Runzhe Shu, et al.
Published: (2023-11-01)